Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Net Margin (2016 - 2025)

Nephros has reported Net Margin over the past 16 years, most recently at 1.31% for Q4 2025.

  • Quarterly results put Net Margin at 1.31% for Q4 2025, down 809.0% from a year ago — trailing twelve months through Dec 2025 was 6.47% (up 589.0% YoY), and the annual figure for FY2025 was 6.35%, up 583.0%.
  • Net Margin for Q4 2025 was 1.31% at Nephros, down from 7.07% in the prior quarter.
  • Over the last five years, Net Margin for NEPH hit a ceiling of 11.87% in Q1 2025 and a floor of 134.12% in Q3 2022.
  • Median Net Margin over the past 5 years was 10.55% (2023), compared with a mean of 24.38%.
  • Biggest five-year swings in Net Margin: plummeted -8672bps in 2022 and later skyrocketed 12926bps in 2023.
  • Nephros' Net Margin stood at 40.66% in 2021, then grew by 12bps to 35.89% in 2022, then soared by 44bps to 20.1% in 2023, then soared by 147bps to 9.41% in 2024, then plummeted by -86bps to 1.31% in 2025.
  • The last three reported values for Net Margin were 1.31% (Q4 2025), 7.07% (Q3 2025), and 5.36% (Q2 2025) per Business Quant data.